Mechanism of RGD-conjugated nanodevice binding to its target protein integrin α_Vβ₃ by atomistic molecular dynamics...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Computational Biology

Background:

• Active targeting strategies enhance nanoparticle (NP) uptake by diseased cells.
• Mechanistic studies detailing ligand-NP and integrin interactions at the atomic level are lacking.

Purpose of the Study:

• To investigate the atomistic interactions between cyclic-RGD-conjugated PEGylated TiO2 NPs and the extracellular segment of integrin αVβ3.
• To elucidate the role of ligand density in NP-integrin binding for improved targeting selectivity.

Main Methods:

• Advanced molecular dynamics simulations (MD)
• Equilibrium MD
• Binding free energy calculations
• Unsupervised machine learning (self-organized maps)

Main Results:

• Cyclic-RGD ligand binding to integrin αVβ3 remains stable with the NP present.
• Unbound cyclic RGDs significantly contribute to NP-integrin interactions.
• Increased cyclic RGD density on NPs proportionally enhances NP-integrin binding.

Conclusions:

• Understanding NP-integrin interactions at the atomistic level is crucial for designing effective targeted therapies.
• Optimizing ligand density on NPs can improve targeting selectivity and cellular uptake.
• These findings support the development of more successful nanomedicines for clinical applications.